Could a daily turmeric shot boost your health after 60?
NCT ID NCT07196514
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study explores whether drinking turmeric shots twice daily for 8 weeks can improve fatigue, cholesterol, and brain health in healthy older adults. Researchers will compare the turmeric group to a placebo group. The goal is to see if turmeric, beyond its active compound curcumin, offers broad health benefits for aging.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- turmeric
- What this could lead to
- If it works, this could suggest that turmeric supplements improve fatigue, cholesterol, or brain health in older adults.
- What could go wrong
- This is a small, early-stage study in healthy people, so results may not apply to those with health conditions. The effects may be small or no different from placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2025
- Expected to finish
-
Jul 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 to 95 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: \- Body Mass Index between 18.5-39.9. Exclusion Criteria: * History of, or currently diagnosed with, a cardiovascular disease. * Diagnosed with diabetes. * Diagnosed with a liver, lung, or kidney disease. * Diagnosed with osteoporosis. * Diagnosed with dementia. * Diagnosed with cancer. * Use of medications/supplements/herbal remedies with human evidence of a significant interaction with turmeric. * Allergy to turmeric, lemon, black pepper, watermelon, water, pineapple, magnesium or vitamin C. * Pregnant, attempting to become pregnant, or breastfeeding. * Regular (once per week or more) use of turmeric shots / supplements within the last 3 months.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Placebo are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Nottingham Trent University, Clifton campus
RECRUITINGNottingham, NG11 8NS, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single spinal injection transform Post-Surgery pain relief?
- Can a sleep pill boost success in opioid treatment?
- Caffeine's Muscle-Boosting power may fade with age
- Grief pill study stalls: naltrexone trial ends early
- Seeing is believing: your brain can learn to feel less pain by watching others
- Opioid blocker may reveal Brain's social secrets